Kura Oncology, Inc. (KURA): Free Cash Flow
-$70.70M
Year ended 2025-12-31
-$117.43M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$70.70M | n/m | 2026-03-05, From 2025-01-01 |
| 2024-12-31 | $133.84M | n/m | 2026-03-05, From 2024-01-01 |
| 2023-12-31 | -$124.99M | n/m | 2026-03-05, From 2023-01-01 |
| 2022-12-31 | -$110.69M | n/m | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | -$105.70M | n/m | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | -$72.00M | n/a | 2023-02-23, From 2020-01-01 |
| No annual figure between 2015-12-31 and 2020-12-31. | |||
| 2015-12-31 | -$17.99M | n/a | 2017-03-14, From 2015-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | 2025-12-31 | -$70.70M | n/m |
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | -$1.20M | n/m |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | -$32.17M | n/m |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | -$276.89M | n/m |
| Fortress Biotech, Inc. (FBIO) | 2024-12-31 | -$80.19M | n/m |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | -$41.16M | n/m |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | -$252.03M | n/m |
| Tango Therapeutics, Inc. (TNGX) | 2025-12-31 | -$139.93M | n/m |
| Journey Medical Corp (DERM) | 2024-12-31 | -$24.13M | n/m |
Compare KURA, RMTI, ENTA, VRDN side by side · Screen every company in Pharmaceutical Preparations ↗